IGF-1 signalling is heavily implicated in RA pathology, with early in vivo studies suggesting mild positive effects from its inhibition on IL-6 levels and fibroblast proliferation (Erlandsson et al, 2017; Zhang et al, 2019). Here, IL6 is linked to rheumatoid arthritis.